Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma

References

1. 1.↵
   1. Hilden JM,
   2. Meerbaum S,
   3. Burger P, et al

   . Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 2004;22:2877–84 doi:10.1200/JCO.2004.07.073 pmid:15254056

   Abstract/FREE Full Text
2. 2.↵
   1. Morgenstern DA,
   2. Gibson S,
   3. Brown T, et al

   . Clinical and pathological features of paediatric malignant rhabdoid tumours. Pediatr Blood Cancer 2010;54:29–34 doi:10.1002/pbc.22231 pmid:19653294

   CrossRefPubMed
3. 3.↵
   1. Burger PC,
   2. Yu IT,
   3. Tihan T, et al

   . Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma. Am J Surg Pathol 1998;22:1083–92 doi:10.1097/00000478-199809000-00007 pmid:9737241

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Haberler C,
   2. Laggner U,
   3. Slavc I, et al

   . Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 2006;30:1462–68 doi:10.1097/01.pas.0000213329.71745.ef pmid:17063089

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Biegel JA,
   2. Tan L,
   3. Zhang F, et al

   . Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 2002;8:3461–67 pmid:12429635

   Abstract/FREE Full Text
6. 6.↵
   1. Judkins AR,
   2. Mauger J,
   3. Ht A, et al

   . Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004;28:644–50 pmid:15105654

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Pfister SM,
   2. Korshunov A,
   3. Kool M, et al

   . Molecular diagnostics of CNS embryonal tumors. Acta Neuropathol 2010;120:553–66 doi:10.1007/s00401-010-0751-5 pmid:20882288

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Hasselblatt M,
   2. Gesk S,
   3. Oyen F, et al

   . Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 2011;35:933–35 doi:10.1097/PAS.0b013e3182196a39 pmid:21566516

   CrossRefPubMed
9. 9.↵
   1. Schneppenheim R,
   2. Frühwald MC,
   3. Gesk S, et al

   . Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 2010;86:279–84 doi:10.1016/j.ajhg.2010.01.013 pmid:20137775

   CrossRefPubMed
10. 10.↵
    1. Kerleroux B,
    2. Cottier JP,
    3. Janot K, et al

    . Posterior fossa tumors in children: radiological tips and tricks in the age of genomic tumor classification and advance MR technology. J Neuroradiol 2020;47:46–53 doi:10.1016/j.neurad.2019.08.002 pmid:31541639

    CrossRefPubMed
11. 11.↵
    1. Raybaud C,
    2. Ramaswamy V,
    3. Taylor MD, et al

    . Posterior fossa tumors in children: developmental anatomy and diagnostic imaging. Childs Nerv Syst 2015;31:1661–76 doi:10.1007/s00381-015-2834-z pmid:26351220

    CrossRefPubMed
12. 12.↵
    1. Rumboldt Z,
    2. Camacho DL,
    3. Lake D, et al

    . Apparent diffusion coefficients for differentiation of cerebellar tumors in children. AJNR Am J Neuroradiol 2006;27:1362–69 pmid:16775298

    PubMedWeb of Science
13. 13.↵
    1. Sathyakumar K,
    2. Mani S,
    3. Pathak GH, et al

    . Neuroimaging of pediatric infratentorial tumors and the value of diffusion-weighted imaging (DWI) in determining tumor grade. Acta Radiol 2021;62:533–40 doi:10.1177/0284185120933219 pmid:32539423

    CrossRefPubMed
14. 14.↵
    1. Dufour C,
    2. Beaugrand A,
    3. Le Deley MC, et al

    . Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 2012;118:3812–21 doi:10.1002/cncr.26684 pmid:22180295

    CrossRefPubMed
15. 15.↵
    1. von Hoff K,
    2. Hinkes B,
    3. Dannenmann-Stern E, et al

    . Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 2011;57:978–85 doi:10.1002/pbc.23236 pmid:21796761

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Gajjar A,
    2. Chintagumpala M,
    3. Ashley D, et al

    . Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006;7:813–20 doi:10.1016/S1470-2045(06)70867-1 pmid:17012043

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Gandola L,
    2. Massimino M,
    3. Cefalo G, et al

    . Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma. J Clin Oncol 2009;27:566–71 doi:10.1200/JCO.2008.18.4176 pmid:19075266

    CrossRefPubMed
18. 18.↵
    1. Jakacki RI,
    2. Burger PC,
    3. Zhou T, et al

    . Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children’s Oncology Group Phase I/II study. J Clin Oncol 2012;30:2648–53 doi:10.1200/JCO.2011.40.2792 pmid:22665539

    Abstract/FREE Full Text
19. 19.↵
    1. Biswas A,
    2. Kashyap L,
    3. Kakkar A, et al

    . Atypical teratoid/rhabdoid tumors: challenges and search for solutions. Cancer Manag Res 2016;8:115–25 doi:10.2147/CMAR.S83472 pmid:27695363

    CrossRefPubMed
20. 20.↵
    1. Northcott PA,
    2. Robinson GW,
    3. Kratz CP, et al

    . Medulloblastoma. Nat Rev Dis Primers 2019;5:11 doi:10.1038/s41572-019-0063-6 pmid:30765705

    CrossRefPubMed
21. 21.↵
    1. Lambin P,
    2. Leijenaar RT,
    3. Deist TM, et al

    . Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 2017;14:749–62 doi:10.1038/nrclinonc.2017.141 pmid:28975929

    CrossRefPubMed
22. 22.↵
    1. Napel S,
    2. Mu W,
    3. Jardim-Perassi BV, et al

    . Quantitative imaging of cancer in the postgenomic era: radio(geno)mics, deep learning, and habitats. Cancer 2018;124:4633–49 doi:10.1002/cncr.31630 pmid:30383900

    CrossRefPubMed
23. 23.↵
    1. Li R,
    2. Xing L,
    3. Napel S, et al

    . Radiomics and Radiogenomics: Technical Basis and Clinical Applications. Chapman & Hall/CRC; 2021
24. 24.↵
    1. Dong J,
    2. Li L,
    3. Liang S, et al

    . Differentiation between ependymoma and medulloblastoma in children with radiomics approach. Acad Radiol 2021;28:318–27 doi:10.1016/j.acra.2020.02.012 pmid:32222329

    CrossRefPubMed
25. 25.↵
    1. Zhou H,
    2. Hu R,
    3. Tang O, et al

    . Automatic machine learning to differentiate pediatric posterior fossa tumors on routine MR imaging. AJNR Am JNeuroradiol 2020;41:1279–85 doi:10.3174/ajnr.A6621 pmid:32661052

    Abstract/FREE Full Text
26. 26.↵
    1. Payabvash S,
    2. Aboian M,
    3. Tihan T, et al

    . Machine learning decision tree models for differentiation of posterior fossa tumors using diffusion histogram analysis and structural MRI findings. Front Oncol 2020;10:71 doi:10.3389/fonc.2020.00071 pmid:32117728

    CrossRefPubMed
27. 27.↵
    1. Ho DM,
    2. Hsu CY,
    3. Wong TT, et al

    . Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol 2000;99:482– 88 doi:10.1007/s004010051149 pmid:10805090

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Mattonen SA,
    2. Gude D,
    3. Echegaray S, et al

    . Quantitative imaging feature pipeline: a web-based tool for utilizing, sharing, and building image-processing pipelines. J Med Imaging (Bellingham) 2020;7:042803 doi:10.1117/1.JMI.7.4.042803 pmid:32206688

    CrossRefPubMed
29. 29.↵
    1. van Griethuysen JJ,
    2. Fedorov A,
    3. Parmar C, et al

    . Computational radiomics system to decode the radiographic phenotype. Cancer Res 2017;77:e104–07 doi:10.1158/0008-5472.CAN-17-0339 pmid:29092951

    Abstract/FREE Full Text
30. 30.↵
    1. Zwanenburg A,
    2. Vallières M,
    3. Abdalah MA, et al

    . The Image Biomarker Standardization Initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 2020;295:328–38 doi:10.1148/radiol.2020191145 pmid:32154773

    CrossRefPubMed
31. 31.↵
    1. Echegaray S,
    2. Bakr S,
    3. Rubin DL, et al

    . Quantitative Image Feature Engine (QIFE): an open-source, modular engine for 3D quantitative feature extraction from volumetric medical images. J Digit Imaging 2018;31:403–14 doi:10.1007/s10278-017-0019-x pmid:28993897

    CrossRefPubMed
32. 32.↵
    1. Lefkowitz IB

    . Atypical teratoid tumor of infancy: definition of an entity. Ann Neurol 1987;22:448–44 pmid:8683283

    PubMed
33. 33.↵
    1. Rorke LB,
    2. Packer RJ,
    3. Biegel JA

    . Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56–65 doi:10.3171/jns.1996.85.1.0056 pmid:8683283

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Biegel JA,
    2. Fogelgren B,
    3. Zhou JY, et al

    . Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system. Clin Cancer Res 2000;6:2759–63 pmid:10914721

    Abstract/FREE Full Text
35. 35.↵
    1. Gessi M,
    2. Giangaspero F,
    3. Pietsch T

    . Atypical teratoid/rhabdoid tumors and choroid plexus tumors: when genetics “surprise” pathology. Brain Pathol 2003;13:409–14 doi:10.1111/j.1750-3639.2003.tb00039.x pmid:12946029

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Warmuth-Metz M,
    2. Bison B,
    3. Dannemann-Stern E, et al

    . CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology 2008;50:447–52 doi:10.1007/s00234-008-0369-7 pmid:18345534

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Jin B,
    2. Feng XY

    . MRI features of atypical teratoid/rhabdoid tumors in children. Pediatr Radiology 2013;43:1001–08 doi:10.1007/s00247-013-2646-9 pmid:23467756

    CrossRefPubMed
38. 38.↵
    1. Perreault S,
    2. Ramaswamy V,
    3. Achrol AS, et al

    . MRI surrogates for molecular subgroups of medulloblastoma. AJNR Am J Neuroradiol 2014;35:1263–69 doi:10.3174/ajnr.A3990 pmid:24831600

    Abstract/FREE Full Text
39. 39.↵
    1. Yeom KW,
    2. Mobley BC,
    3. Lober RM, et al

    . Distinctive MRI features of pediatric medulloblastoma subtypes. AJR Am J Roentgenol 2013;200:895–903 doi:10.2214/AJR.12.9249 pmid:23521467

    CrossRefPubMed
40. 40.↵
    1. Graadt van Roggen JF,
    2. Hogendoorn PC,
    3. Fletcher CD

    . Myxoid tumours of soft tissue. Histopathology 1999;35:291–12 doi:10.1046/j.1365-2559.1999.00835.x pmid:10564384

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Koeller KK,
    2. Rushing EJ

    . From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. Radiographics 2003;23:1613–37 doi:10.1148/rg.236035168 pmid:14615567

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Cheng YC,
    2. Lirng JF,
    3. Chang FC, et al

    . Neuroradiological findings in atypical teratoid/rhabdoid tumor of the central nervous system. Acta Radiol 2005;46:89–96 doi:10.1080/02841850510020987 pmid:15841745

    CrossRefPubMed
43. 43.
    1. Meyers SP,
    2. Khademian ZP,
    3. Biegel JA, et al

    . Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes. AJNR Am J Neuroradiol 2006;27:962–71 pmid:16687525

    PubMedWeb of Science
44. 44.↵
    1. Bruggers CS,
    2. Moore K

    . Magnetic resonance imaging spectroscopy in pediatric atypical teratoid rhabdoid tumors of the brain. J Pediatr Hematol Oncol 2014;36:e341–45 doi:10.1097/MPH.0000000000000041 pmid:24072251

    CrossRefPubMed
45. 45.↵
    1. Parmar H,
    2. Hawkins C,
    3. Bouffet E, et al

    . Imaging findings in primary intracranial atypical teratoid/rhabdoid tumors. Pediatr Radiol 2006;36:126–32 doi:10.1007/s00247-005-0037-6 pmid:16341528

    CrossRefPubMed
46. 46.↵
    1. Schittenhelm J,
    2. Nagel C,
    3. Meyermann R, et al

    . Atypical teratoid/rhabdoid tumors may show morphological and immunohistochemical features seen in choroid plexus tumors. Neuropathology 2011;31:461–67 doi:10.1111/j.1440-1789.2010.01189.x pmid:21276081

    CrossRefPubMed
47. 47.↵
    1. Brandão LA,
    2. Poussaint TY

    . Pediatric brain tumors. Neuroimaging Clin N Am 2013;23:499–525 doi:10.1016/j.nic.2013.03.003 pmid:23928202

    CrossRefPubMed